<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01848717</url>
  </required_header>
  <id_info>
    <org_study_id>HANS_MINTLIFT_1101</org_study_id>
    <nct_id>NCT01848717</nct_id>
  </id_info>
  <brief_title>Evaluate the Efficacy and Safety of MINTLIFT® Group for Nasolabial Fold</brief_title>
  <official_title>A Single‐Center, Single Arm, Pre-post Test Design, Open Clinical Study to Evaluate the Efficacy and Safety of MINTLIFT® Group for Nasolabial Fold</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chung-Ang University Hosptial, Chung-Ang University College of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>HansBiomed Co.,Ltd.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Chung-Ang University Hosptial, Chung-Ang University College of Medicine</source>
  <brief_summary>
    <textblock>
      The objective of this clinical test is to verify the safety and efficacy of MINTLIFT®, used
      for the purpose of improving the appearance of the nasolabial fold on both sides of the face.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2012</start_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The percentage of the subjects who demonstrated wrinkle improvement to -1 or below in WSRS as determined by an independent evaluator</measure>
    <time_frame>12th week of the application of the test device</time_frame>
    <description>The percentage of the subjects within the test group who demonstrated wrinkle improvement to -1 or below in WSRS in the 12th week following the application of the device in comparison to the condition prior to the application (12th week- prior to application) as determined by an independent evaluator</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The percentage of the subjects who demonstrated wrinkle improvement to -1 or below in WSRS as determined by an independent evaluator</measure>
    <time_frame>in the 4th, 8th and 24th week following the application of the device</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The percentage of the subjects who demonstrated wrinkle improvement to -1 or below in WSRS as determined by the investigator</measure>
    <time_frame>in the 4th, 8th, 12th and 24th week following the application of the device</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The average of the differences between the baseline and the WSRS evaluated by the independent evaluator</measure>
    <time_frame>in the 4th, 8th, 12th and 24th week following the application of the test device</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The average of the differences between the baseline and the WSRS evaluated by the subject</measure>
    <time_frame>in the 4th, 8th, 12th and 24th week following the application of the test device</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The average value of Global Aesthetic Improvement Scale (GAIS) scores as determined by the investigator and the distribution of scores</measure>
    <time_frame>in the 12th and 24th week following the application of the test device</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The average value of GAIS scores as determined by the subject and the distribution of scores</measure>
    <time_frame>in the 12th and 24th week following the application of the test device</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">62</enrollment>
  <condition>Nasolabial Fold</condition>
  <arm_group>
    <arm_group_label>Lift thread</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MINTLIFT®</intervention_name>
    <arm_group_label>Lift thread</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Individuals who desire an improvement in the appearance of the nasolabial fold on both
             sides of the face and who have a score of 3 or 4 on the Wrinkle Severity Rating Scale
             (WSRS) at the time of the screening and at the baseline time point

          -  Individuals who have consented to abstain from any other dermatological procedures or
             treatments, including treatments for wrinkle reduction in the facial area, during the
             duration of this clinical test

        Exclusion Criteria:

          -  Subjects who have a scar or hypertrophic scar or a history of keloid conditions that
             may affect the determination of effect

          -  Subjects allergic to local anesthetics or sleep anesthetics

          -  Subjects whose ALT/AST ratio is 2.5 times or more greater than the normal upper limit

          -  Subjects who have been administered an anticoagulant (with the exception of low dosage
             aspirin (100mg, up to 300mg/day)) within 2 weeks of the date of the screening, or who
             require an anticoagulant during the period of the clinical test

          -  Subjects who have been administered systemic corticosteroids or anabolic steroids
             within two weeks of the date of the screening or who require their administration
             during the period of the clinical test (note, however, that the administration of
             inhaled corticosteroids in a standardized dosage is permissible)

          -  Subjects who have been administered Vitamin E or non-steroidal anti-inflammatory drugs
             within 1 week of the date of the screening

          -  Subjects who have used Topical liniments in the facial area (steroids, retinoids: only
             medical drugs are included in this criteria, with the exclusion of cosmetic products)
             within 4 weeks of the date of the screening or who plan on continuing usage during the
             period of the clinical test

          -  Subjects who have received wrinkle reduction treatment using CaHA within 1 year of the
             date of the screening

          -  Subjects who have received wrinkle reduction treatment using collagen or HA filler
             within 6 months of the date of the screening, or who have received acne treatment,
             skin regeneration procedures, or cosmetic surgical procedures (including Botox
             injections) in the facial area

          -  Subjects who have a permanent skin expanding implant such as Softform or silicon
             inserted in the facial area

          -  Subjects who have scars in the facial area requiring treatment that has not healed for
             a period of 1 year or longer, or who have a scar or trace in the area on which the
             clinical test device will applied.

          -  Subjects who have a chronic or recurrent infection or a history of inflammatory
             disease that may affect this clinical test

          -  Subjects who have experienced severe allergies such as symptoms of anaphylaxis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Beom Joon KIM, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Dermatology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Beom Joon KIM, MD, PhD</last_name>
    <phone>+82-2-6299-1525</phone>
    <email>beomjoon74@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Chung-Ang University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>MIN</last_name>
      <phone>+82-2-6299-1525</phone>
      <email>tonhuk28@naver.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 3, 2013</study_first_submitted>
  <study_first_submitted_qc>May 3, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 7, 2013</study_first_posted>
  <last_update_submitted>May 3, 2013</last_update_submitted>
  <last_update_submitted_qc>May 3, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 7, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chung-Ang University Hosptial, Chung-Ang University College of Medicine</investigator_affiliation>
    <investigator_full_name>Beom Joon Kim</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

